← Eichor
Condition: Crohn S Disease Cd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Crohn S Disease Cd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.
NA · 1 location(s) · Xiang Gao · NCT06912815Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Dis
Phase N/A · 1 location(s) · Shanghai 10th People's Hospital · NCT07694674Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Shmuel Kivity, MD · NCT07644117Evaluation of the SMART IBD App in Pediatric IBD
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07195123Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07444060PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
NA · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT06758024TIDHI Mental Health in IBD Patients Study
NA · 1 location(s) · TIDHI Innovation Inc. · NCT07013578A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · 53 location(s) · Takeda · NCT06045754A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · 39 location(s) · Alimentiv Inc. · NCT07363044An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With
Phase N/A · 104 location(s) · AbbVie · NCT06023030Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter
Phase N/A · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT07093294Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopea
Phase N/A · 1 location(s) · Imelda GI Clinical Research Center · NCT07621783Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
NA · 6 location(s) · University of Glasgow · NCT07522528HB-adMSCs for the Treatment of Crohn's Disease
Phase 2 · 1 location(s) · Hope Biosciences Research Foundation · NCT07077746Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
Phase 2 · 1 location(s) · University of Michigan · NCT07556718Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NA · 1 location(s) · Jinling Hospital, China · NCT05658081Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Phase 4 · 6 location(s) · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT07292012Specific Dietary Pattern for Crohn's Disease Patients Following Surgery
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05502965A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Phase 2 · 225 location(s) · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli · NCT06226883A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
Phase N/A · 2 location(s) · Anterogen Co., Ltd. · NCT03183661Treatment of Moderate to Severe Refractory Crohn's Disease
Phase 1/Phase 2 · 13 location(s) · Tr1X, Inc. · NCT06721962Reliability of IUS in Crohn's Disease
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06833450Ibd CAncer and seRious Infections in France (I-CARE 2)
Phase N/A · 2 location(s) · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT06089590Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression
NA · 1 location(s) · GLSMED Learning Health S.A. · NCT06727253Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar
Phase N/A · 11 location(s) · EG Labo · NCT07077681Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the
Phase 1/Phase 2 · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT07629245Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in
Phase N/A · 2 location(s) · Asian Institute of Gastroenterology, India · NCT07431983Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY
Phase N/A · 1 location(s) · Fondazione Poliambulanza Istituto Ospedaliero · NCT07111715
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.